CEO of Pharmerica Corp (NYSE:PMC) Gregory S Weishar sold 521,089 shares of PMC on 12/07/2017 at an average price of $29.25 a share. The total sale was $15.2 million.
Pharmerica Corp is engaged in providing pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting, and offers national oncology pharmacy in the United States. PharMerica Corp has a market cap of $910.270 million; its shares were traded at around $29.25 with a P/E ratio of 47.95 and P/S ratio of 0.40. PharMerica Corp had annual average EBITDA growth of 3.60% over the past five years.
CEO Recent Trades:
CEO Gregory S Weishar sold 521,089 shares of PMC stock on 12/07/2017 at the average price of $29.25. The price of the stock has decreased by 0% since.
Directors and Officers Recent Trades:
Senior Officer Edward Leith Ellwood, sold 20,000 shares of PMC stock on 12/06/2017 at the average price of $0.09.
For the complete insider trading history of PMC, click here
.
